Janice Chang

Janice Chang is the Chief Operating Officer at TransCelerate BioPharma Inc. Janice has been involved with the organization since its inception. In her current position, Janice works closely with the CEO and the Board of Directors to shape the long-term strategic vision and priorities for the organization and its 30+ initiatives. Janice defines and guides TransCelerate’s overall external engagement strategy with global health authorities, governmental agencies, industry groups, and TransCelerate’s country network spanning across 30 countries. She has accountability overseeing TransCelerate’s corporate operations and works closely with her team to drive strategic delivery of TransCelerate’s portfolio.

Janice also actively participates in various cross-stakeholder global discussions to help evolve our R&D paradigm. Most recently she joined the Advisory Council for HL7 International’s Vulcan Accelerator. Vulcan is a global strategic effort to bring together stakeholders across the translational and clinical research community to align on data exchange standards to bridge existing gaps between clinical care and clinical research, enabling more effective acquisition, exchange and use of healthcare data in translational and clinical research.

With a background of 20+ years of experience leading initiatives in large pharma and biotech companies, Janice has experience spanning across regulatory, clinical, and manufacturing. Janice is passionate in driving meaningful change across our ecosystem and not settling for the status quo. She believes in reimagining the way we advance innovative medicine and advocates for the power of open collaboration across stakeholder groups.